Scott Morrison Purchases 987 Shares of CVS Group (LON:CVSG) Stock

CVS Group plc (LON:CVSGGet Free Report) insider Scott Morrison acquired 987 shares of CVS Group stock in a transaction dated Wednesday, May 27th. The shares were acquired at an average price of GBX 1,270 per share, with a total value of £12,534.90.

CVS Group Stock Down 0.2%

Shares of LON CVSG opened at GBX 1,237 on Thursday. CVS Group plc has a 1 year low of GBX 1,062 and a 1 year high of GBX 1,648. The stock has a market capitalization of £867.84 million, a P/E ratio of 17.95, a P/E/G ratio of 1.77 and a beta of 1.02. The company has a 50-day moving average price of GBX 1,173.59 and a 200-day moving average price of GBX 1,244.57. The company has a debt-to-equity ratio of 121.52, a current ratio of 1.07 and a quick ratio of 0.90.

CVS Group (LON:CVSGGet Free Report) last released its quarterly earnings results on Thursday, February 26th. The company reported GBX 40.20 earnings per share for the quarter. CVS Group had a net margin of 2.31% and a return on equity of 5.35%. On average, equities research analysts forecast that CVS Group plc will post 93.9393939 EPS for the current fiscal year.

CVS Group declared that its board has authorized a stock repurchase program on Tuesday, May 26th that permits the company to buyback 0 outstanding shares. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several brokerages have commented on CVSG. Berenberg Bank reaffirmed a “buy” rating and issued a GBX 2,000 price objective on shares of CVS Group in a research report on Tuesday. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a GBX 1,900 price objective on shares of CVS Group in a research report on Thursday, March 5th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of GBX 1,724.

Read Our Latest Stock Analysis on CVS Group

CVS Group Company Profile

(Get Free Report)

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

Read More

Insider Buying and Selling by Quarter for CVS Group (LON:CVSG)

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.